Retracted: Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma (International Journal of Cancer, (2005), 114, 2, (242-248), 10.1002/ijc.20711);Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma

International Journal of Cancer

Volumn 114, Issue 2, 2005, Pages 242-248

  Garcia Pedrero, Juana Maria ^a   Garcia Carracedo, Dario ^a   Muñoz Pinto, Cristina ^b   Herrero Zapatero, Agustín ^b   Rodrigo, Juan Pablo ^a,b   Suarez Nieto, Carlos ^a,b   Gonzalez, Maria Victoria ^a,c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

AKT2; Head and neck squamous cell carcinoma; PIK3CA; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADULT; AKT2 GENE; ARTICLE; FEMALE; GENE; GENE AMPLIFICATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PIK3C GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTEN GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

EID: 13244265590     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.32347     Document Type: Erratum

References (34)

1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1998;18:4779-86.
2. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
3. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washingon DC) 1997;275:1943-7.
4. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, et al. Identification of a candidate tumor suppressor gene, MMAC1, to chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.
5. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phophoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 1999;96:4240-55.
6. Di Cristofano A, Pesce B, Cordón-Cardo C, Pandolfi PP. PTEN is essential for embryonic development and tumor suppression. Nat Genet 1998;19:348-55.
7. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sazaki T, Ruland J, Penninger JM, Sideroxski DP, Mak TW. Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell 1998;95:29-39.
8. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999;21:99-102.
9. Ma Y, Wei S, Lin Yu, Lung J, Chang T, Whang-Peng J, Liu J, Yang D, Yang W, Shen C. P1K3CA as an oncogene in cervical cancer. Oncogene 2000;19:2739-44.
10. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR. Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci 1996;93:3636-41.
11. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare CA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandia G, Panici PB, et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 1995;64:280-5.
12. Bockmühl U, Petersen S, Shmidt S, Wolf G, Jahnke V, Dietel M, Petersen I. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 1997;57:5213-6.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
14. Sobin LH, Wittekind C. UICC. TNM classification of malignant tumors,6th ed. New York: Wiley-Liss, 2002.
15. Hamilton JA, Stewart LMD, Ajayi L, Gray IC, Gray ME., Roberts KG, Watson GJ, Kaisary AV, Snary D. The expression profile for the tumor suppressor gene PTEN and associated polymorphic markers. Br J Cancer 2000;82:1671-76.
16. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
17. Gonzalez MV, Pello MF, López-Larrea C, Suarez C, Menendez MJ, Goto E. Deletion and methylation of the tumor suppresor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J Clin Pathol 1997;50:509-12.
18. Aoki M, Schetter C, Himly M, Batista O, Chang HW, Vogt PK. The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J Biol Chem 2000;275:6267-75.
19. Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, de Manoir S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas : PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 2001;61:4122-9.
20. Bockmühl U, Schluns K, Kuchler I, Petersen S, Petersen I. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 2000;157:369-75.
21. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. Rapid AKT activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003;111:81-90.
22. Petersen L Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel M, Ried T, Dietel M. Small cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p,4q,5q,10q.13q and 17p. Br J Cancer 1997;75:79-86.
23. Bockmühl U, Schwendel A, Dietel M, Peterson I. Distinct patterns of chromosomal alterations in high and low grade head and neck squamous cell carcinomas. Cancer Res 1996;56:5325-9.
24. Ruggeri BA, Huang L, Wood M, Cheng JQ, Testa JR. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol Carcinog 1998;21:81-6.
25. Snaddon J, Parkinson EK, Craft JA, Bartholomew C, Fulton R. Detection of functional PTEN lipid phosphastase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 2001;84:1630-4.
26. Di Cristofano A, Pandolfi PP. Multiple roles of PTEN in tumor suppression. Cell 2000;100:387-90.
27. Lee JI, Soria J-C, Hassan KA, El-Naggar EK, Tang X, Liu DD, Hong WK, Mao L. Loss of PTEN expression as a prognostic marker for tongue cancer. Arch. Otolarygol. Head Neck Surg 2001;127:1441-5.
28. Okami K, Wu L, Riggins G, Cairns P, Goggins M, Evron E, Halachmi N, Ahrendt SA, Reed AL, Hilgers W, Kern SE, Koch WM, Sidransky D, Jen J. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res 1998;58:509-11.
29. Myers MP, Pass I, Batty IH, Van Der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci U S A 1998;95:13513-8.
30. Poetsch M, Lorenz G, Kleist B. Detection of new PTEN/MMAC1 deletions in head and neck squamous cell carcinomas with loss of chromosome 10. Cancer Genet Cytogenet 2002;132:20-4.
31. Henderson YC, Wang E, Clayman GL. Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas. Laryngoscope 1998;108:1553-6.
32. Chen Q, Samaranayake LP, Zhou H, Xiao L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol 2000;36:95-9.
33. Whang YE, Xinyi W, Suzuki H, Reitler RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A 1998;95:5246-50.
34. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953;6:963-8.